The report presents a comprehensive overview of industry trends, growth share and the competitive landscape in 200 pages.
“Biomarker Testing Services Market” report contains detailed information on factors influencing demand, growth, opportunities, challenges, and restraints. It provides detailed information about the structure and prospects for global and regional industries. In addition, the report includes data on research & development, new product launches, product responses from the global and local markets by leading players. The structured analysis offers a graphical representation and a diagrammatic breakdown of the Biomarker Testing Services Market by region.
Global Biomarker Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029.
Request To Download Sample of This Strategic Report: –https://www.quadintel.com/request-sample/global-biomarker-testing-services-market/3-2-1744
Biomarker testing services give a powerful approach to measuring a biological process and act as an indicator in normal as well as pathological conditions in response to pharmacological intervention. To research human diseases, doctors have used biomarker analysis in blood or other body fluids at the DNA or protein level for many years. Clinical illnesses such as cancer, immunological responses, genetic disorders, and cardiovascular diseases are among the conditions that doctors frequently use biomarker services to identify and treat. The Biomarker Testing Services market is expanding because of factors such as increasing demand for biomarker testing for cancer detection and increasing R&D activities.
New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific’s expected significant growth during the forecast period.
Download Sample of This Strategic Report: –https://www.quadintel.com/request-sample/global-biomarker-testing-services-market/3-2-1744
Major market players included in this report are:
- Bio Agilytix Labs
- Eurofins Scientific
- SGS SA
- Charles River Laboratories
- Labcorp Drug Development
- Thermo Fisher Scientific Inc. (PPD, Inc.)
- ICON Plc
- IQVIA
- Syneos Health
- Intertek Group Plc
Recent Developments in the Market:
- In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
- In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient’s tumor molecular profile, the offer will come in combination with oncodna’s data analysis and clinical interpretation tools.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Request a Sample PDF copy of the report @ –https://www.quadintel.com/request-sample/global-biomarker-testing-services-market/3-2-1744
The detailed segments and sub-segment of the market are explained below:
By Product:
Biomarker Assay Development
Flow Cytometry
Others
By End User:
Pharmaceutical and biotechnology companies
Research Institutes
CRO
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Request full Report Description, TOC, Table of Figure, Chart, etc. @ –https://www.quadintel.com/request-sample/global-biomarker-testing-services-market/3-2-1744
Report Include:
- Market Behavior/ Level of Risk and Opportunity
- End Industry Behavior/ Opportunity Assessment
- Expected Industry Recovery Timeline
Key Market Features in Global Market:The report assessed key market features, including revenue, capacity, price, capacity utilization rate, production rate, gross, production, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. The study also offers a thorough analysis of the most important market factors and their most recent developments, as well as pertinent market segments and sub-segments.
In this report, the following important queries are addressed:
- What is the Global market’s sales value, production value, consumption value, import, and export (including North America, Europe, Asia-Pacific, South America, Middle East, and Africa)?
- Who are the major manufacturers in this sector on a global scale? How are their capacity, production, sales, pricing, cost, gross, and revenue operating?
- What are the vendors’ market prospects and risks in the international industry?
- Which product types, end users, or applications might be looking for additional growth prospects? What is each type’s and application’s market share?
- What specific strategies and limitations are keeping the market in check?
- What is the various marketing, sales, and distribution channels in the international market?
- What are the upstream raw materials, as well as the manufacturing machinery?
- What are the Market opportunities, market risk, and market overview of this industry?
Request Full Report–https://www.quadintel.com/request-sample/global-biomarker-testing-services-market/3-2-1744
About Quadintel:
We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Quadintel:
Email: sales@quadintel.com
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.quadintel.com/